VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AMLChristoph Röllig, Christoph Schliemann, Lars Fransecky et al.|Annals of Hematology|2025Cited by 4